Pharr TX 2型糖尿病临床试验
8项针对 2型糖尿病的研究正在 Pharr及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- Texas Valley Clinical Research, Weslaco · 距离 12 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Weslaco · 距离 12 英里
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Texas Valley Clinical Research, Weslaco · 距离 12 英里
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Texas Valley Clinical Research, Weslaco · 距离 12 英里
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Weslaco · 距离 12 英里
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Texas Valley Clinical Research, LLC, Weslaco · 距离 12 英里
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
招募中2 期
- Texas Valley Clinical Research, Weslaco · 距离 12 英里
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Valley Diab. & Endo Comp Ctr, Weslaco · 距离 12 英里
其他城市的 2型糖尿病试验
- San Antonio, TX36 项研究
- Houston, TX30 项研究
- Orlando, FL24 项研究
- Boston, MA20 项研究
- Miami, FL19 项研究
- Chicago, IL19 项研究
- Columbus, OH18 项研究
- Dallas, TX18 项研究
- Atlanta, GA17 项研究
- Las Vegas, NV17 项研究
- Birmingham, AL16 项研究
- New York City, NY16 项研究
Pharr的其他研究
数据来自 ClinicalTrials.gov,检索日期:2026年9月30日。每项研究自行设定入选标准,由研究团队决定谁能参与。